Crossmark

Treatment with a mineralocorticoid receptor blocker esaxerenone on top of the first-line therapy: promise in uncontrolled hypertension

Published Online: 2024-10-17

Published Print: 2024-12

Authors

Mukoyama, Masashi
License Information

Text and Data Mining valid from 2024-10-17

Version of Record valid from 2024-10-17
More Information

Article History

Received: 26 September 2024

Accepted: 5 October 2024

First Online: 17 October 2024

Compliance with ethical standards

:

: The author declares no competing interests.

Free to read: This content has been made available to all.

Document is current